110 related articles for article (PubMed ID: 24460336)
41. Promoter hypermethylation of SLIT2 is a risk factor and potential diagnostic biomarker for nasopharyngeal carcinoma.
Li J; Zhou C; Wang G; Wang S; Ni S; Ye M; Zhang J
Gene; 2018 Feb; 644():74-79. PubMed ID: 29107007
[TBL] [Abstract][Full Text] [Related]
42. A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction.
Bel Hadj Jrad B; Mahfouth W; Bouaouina N; Gabbouj S; Ahmed SB; Ltaïef M; Jalbout M; Chouchane L
Cancer Lett; 2006 Feb; 233(1):21-7. PubMed ID: 16473667
[TBL] [Abstract][Full Text] [Related]
43. Association between polymorphism of tumour necrosis factor alpha-308 gene promoter and asthma: a meta-analysis.
Gao J; Shan G; Sun B; Thompson PJ; Gao X
Thorax; 2006 Jun; 61(6):466-71. PubMed ID: 16517578
[TBL] [Abstract][Full Text] [Related]
44. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.
Abedinzadeh M; Zare-Shehneh M; Neamatzadeh H; Abedinzadeh M; Karami H
Asian Pac J Cancer Prev; 2015; 16(11):4525-30. PubMed ID: 26107198
[TBL] [Abstract][Full Text] [Related]
45. Promoter hypermethylation along with LOH, but not mutation, contributes to inactivation of DLC-1 in nasopharyngeal carcinoma.
Feng X; Ren C; Zhou W; Liu W; Zeng L; Li G; Wang L; Li M; Zhu B; Yao K; Jiang X
Mol Carcinog; 2014 Nov; 53(11):858-70. PubMed ID: 23908159
[TBL] [Abstract][Full Text] [Related]
46. Meta-analysis of the Correlation Between Interleukin-6 Promoter Polymorphism -174G/C and Interferon Regulatory Factor 4 rs12203592 Polymorphism With Skin Cancer Susceptibility.
Wu M; Cao Y; Liu YL; Ma LL; Yang XH
Am J Ther; 2016; 23(6):e1758-e1767. PubMed ID: 26928068
[TBL] [Abstract][Full Text] [Related]
47. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma.
Ben Nasr H; Chahed K; Mestiri S; Bouaouina N; Snoussi K; Chouchane L
Hum Immunol; 2007 Sep; 68(9):761-9. PubMed ID: 17869651
[TBL] [Abstract][Full Text] [Related]
48. Multigene pathway-based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT-CLPTM1L and DNA double-strand breaks repair.
Yee Ko JM; Dai W; Wun Wong EH; Kwong D; Tong Ng W; Lee A; Kai Cheong Ngan R; Chung Yau C; Tung S; Li Lung M
Int J Cancer; 2014 Oct; 135(7):1634-45. PubMed ID: 24615621
[TBL] [Abstract][Full Text] [Related]
49. p53, latent membrane protein 1, bcl-2, and prognosis in nasopharyngeal carcinoma: a meta-analysis.
Yang GD; Wang ZC; Chen QY; Zhang HL; Lin XG; Huang TJ; Qian CN; Huang BJ
Histol Histopathol; 2019 Feb; 34(2):103-110. PubMed ID: 30063067
[TBL] [Abstract][Full Text] [Related]
50. Association between interleukin-18 gene promoter (- 607C/A and - 137G/C) polymorphisms and chronic hepatitis C virus infections: A meta-analysis.
Yang Y; Liu H
Meta Gene; 2015 Sep; 5():21-31. PubMed ID: 26042207
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-18 -137 G/C and -607 C/A polymorphisms and Alzheimer's disease risk: a meta-analysis.
Zhang J; Song T; Liang H; Lian J; Zhang G; Gong H
Neurol Sci; 2016 Jun; 37(6):921-7. PubMed ID: 26897018
[TBL] [Abstract][Full Text] [Related]
52. The HLA-DRB1 allele polymorphisms and nasopharyngeal carcinoma.
Yang H; Yu K; Zhang R; Li J; Wei X; Zhang Y; Zhang C; Xiao F; Zhao D; Lin X; Wu H; Yang X
Tumour Biol; 2016 Jun; 37(6):7119-28. PubMed ID: 27059731
[TBL] [Abstract][Full Text] [Related]
53. Association between the -607 C > A polymorphism in interleukin-18 gene promoter with gastrointestinal cancer risk: a meta-analysis.
Yao J; Li ZH; Li YX; Zhang R; Zhang DG; Xu ZL; Wang LS; Wang JY
Genet Mol Res; 2015 Dec; 14(4):16880-7. PubMed ID: 26681034
[TBL] [Abstract][Full Text] [Related]
54. Analysis of the Association of Matrix Metalloproteinase-1 Gene Promoter (rs1799750) Polymorphism and Risk of Ovarian Cancer.
Wang L; Kong B
Int J Gynecol Cancer; 2015 Jul; 25(6):961-7. PubMed ID: 25950130
[TBL] [Abstract][Full Text] [Related]
55. Role of IL-18 Gene Promoter Polymorphisms, Serum IL-18 Levels, and Risk of Hepatitis B Virus-related Liver Disease in the Guangxi Zhuang Population: a Retrospective Case-Control Study.
Lu Y; Bao JG; Deng Y; Rong CZ; Liu YQ; Huang XL; Song LY; Li S; Qin X
Asian Pac J Cancer Prev; 2015; 16(14):6019-26. PubMed ID: 26320490
[TBL] [Abstract][Full Text] [Related]
56. Pin1 promoter rs2233678 and rs2233679 polymorphisms in cancer: a meta-analysis.
Zhu YM; Liu JW; Xu Q; Yuan Y
Asian Pac J Cancer Prev; 2013; 14(10):5965-72. PubMed ID: 24289610
[TBL] [Abstract][Full Text] [Related]
57. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
Ben Nasr H; Hamrita B; Batbout M; Gabbouj S; Bouaouina N; Chouchane L; Chahed K
Clin Chim Acta; 2010 Sep; 411(17-18):1253-7. PubMed ID: 20462505
[TBL] [Abstract][Full Text] [Related]
58. IL-1RN VNTR polymorphism as a susceptibility marker for nasopharyngeal carcinoma in Portugal.
Sousa H; Breda E; Santos AM; Catarino R; Pinto D; Canedo P; Machado JC; Medeiros R
Arch Oral Biol; 2013 Aug; 58(8):1040-6. PubMed ID: 23562526
[TBL] [Abstract][Full Text] [Related]
59. Genetic predisposition of IL-10 promoter polymorphisms with risk of multiple sclerosis: A meta-analysis.
Ramakrishnan V; Akram Husain RS; Ahmed SS
J Neuroimmunol; 2017 May; 306():11-18. PubMed ID: 28385181
[TBL] [Abstract][Full Text] [Related]
60. The protective role of polymorphism MKK4-1304 T>G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus' infection status.
Zheng J; Liu B; Zhang L; Jiang L; Huang B; You Y; Jiang Q; Zhang S; Lu J; Zhou Y
Int J Cancer; 2012 May; 130(9):1981-90. PubMed ID: 21702039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
